DermaSensor. automated skin cancer detection device, DermaSensor Inc., Miami, Florida, USA

[Airicist2]

Developer - DermaSensor Inc.

[Airicist2]

Introducing: DermaSensor - America’s first automated skin cancer detection device for PCPs

Jan 17, 2024

DermaSensor is more than technology; it is a commitment to helping Primary Care Physicians detect skin cancer at the point of care with the first AI-powered medical device for all three common skin cancers.

Now cleared by the U.S. Food and Drug Administration (FDA), DermaSensor equips Primary Care Physicians with immediate, accurate, and objective results that improve skin cancer detection through data-driven breakthrough technologies.

[Airicist2]

"DA Clearance Granted for First AI-Powered Medical Device to Detect All Three Common Skin Cancers (Melanoma, Basal Cell Carcinoma and Squamous Cell Carcinoma)"
DermaSensor Now Available to Improve Skin Cancer Detection in Primary Care

January 17, 2024